
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
Lindsay Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2799-2812
Open Access | Times Cited: 66
Lindsay Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Leukemia (2021) Vol. 35, Iss. 10, pp. 2799-2812
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
High-throughput single-сell sequencing in cancer research
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 103
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 103
Advances in single-cell RNA sequencing and its applications in cancer research
Dezhi Huang, Naya Ma, Xinlei Li, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
Dezhi Huang, Naya Ma, Xinlei Li, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia
Kening Li, Yuxin Du, Yun Cai, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 308-325
Open Access | Times Cited: 56
Kening Li, Yuxin Du, Yun Cai, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 308-325
Open Access | Times Cited: 56
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS
Zhijie Wu, Shouguo Gao, Qingyan Gao, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101160-101160
Open Access | Times Cited: 34
Zhijie Wu, Shouguo Gao, Qingyan Gao, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101160-101160
Open Access | Times Cited: 34
Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia
Hope Mumme, Beena Thomas, Swati S. Bhasin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Hope Mumme, Beena Thomas, Swati S. Bhasin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
Simona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Simona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Causal gene regulatory analysis with RNA velocity reveals an interplay between slow and fast transcription factors
Rohit Singh, Alexander P. Wu, Anish Mudide, et al.
Cell Systems (2024) Vol. 15, Iss. 5, pp. 462-474.e5
Closed Access | Times Cited: 9
Rohit Singh, Alexander P. Wu, Anish Mudide, et al.
Cell Systems (2024) Vol. 15, Iss. 5, pp. 462-474.e5
Closed Access | Times Cited: 9
Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy
Fatemeh Sadat Shafiei, Saeid Abroun, Sadaf Vahdat, et al.
Cancer Genetics (2025) Vol. 292-293, pp. 14-26
Closed Access | Times Cited: 1
Fatemeh Sadat Shafiei, Saeid Abroun, Sadaf Vahdat, et al.
Cancer Genetics (2025) Vol. 292-293, pp. 14-26
Closed Access | Times Cited: 1
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, et al.
HemaSphere (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 6
Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, et al.
HemaSphere (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 6
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
Yanan Zhai, Prashant Singh, Anna Dolnik, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Yanan Zhai, Prashant Singh, Anna Dolnik, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis
Xiu Chen, H. Rosie Xing, Xiaolu Xie, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Xiu Chen, H. Rosie Xing, Xiaolu Xie, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Clinical and biological aspects of myeloid leukemia in Down syndrome
Austin Boucher, Kenneth J. Caldwell, John D. Crispino, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3352-3360
Open Access | Times Cited: 29
Austin Boucher, Kenneth J. Caldwell, John D. Crispino, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3352-3360
Open Access | Times Cited: 29
Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets
Denise Ragusa, Liza Dijkhuis, Cristina Pina, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Denise Ragusa, Liza Dijkhuis, Cristina Pina, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia
Sarah Ennis, Alessandra Jordano Conforte, Eimear O’Reilly, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106943-106943
Open Access | Times Cited: 12
Sarah Ennis, Alessandra Jordano Conforte, Eimear O’Reilly, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106943-106943
Open Access | Times Cited: 12
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance
J Liu, Penglei Jiang, Zezhen Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
J Liu, Penglei Jiang, Zezhen Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat‐Moghadam, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat‐Moghadam, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Prognostic factors and outcomes in pediatric acute myeloid leukemia: a comprehensive bibliometric analysis of global research trends
Mingliang Rao, Wenna Luo, Chenghua Luo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mingliang Rao, Wenna Luo, Chenghua Luo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Hierarchical Lineage Tracing Reveals Diverse Pathways of AML Treatment Resistance
Rachel Saxe, Hugh Stuart, Abigail C. Marshall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Rachel Saxe, Hugh Stuart, Abigail C. Marshall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Single‐cell RNA Sequencing Contributes to the Treatment of Acute Myeloid Leukaemia With Hematopoietic Stem Cell Transplantation, Chemotherapy, and Immunotherapy
Raed Obaid Saleh, Ahmed Hjazi, Safia Obaidur Rab, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
Raed Obaid Saleh, Ahmed Hjazi, Safia Obaidur Rab, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
Single-Cell Atlas of AML Reveals Age-Related Gene Regulatory Networks in t(8;21) AML
Jessica S. Whittle, Stefan Meyer, Georges Lacaud, et al.
(2025)
Open Access
Jessica S. Whittle, Stefan Meyer, Georges Lacaud, et al.
(2025)
Open Access
Single-Cell Atlas of AML Reveals Age-Related Gene Regulatory Networks in t(8;21) AML
Jessica S. Whittle, Stefan Meyer, Georges Lacaud, et al.
(2025)
Open Access
Jessica S. Whittle, Stefan Meyer, Georges Lacaud, et al.
(2025)
Open Access
Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias
Mathilde Poplineau, Nadine Platet, Adrien Mazuel, et al.
Blood (2022) Vol. 140, Iss. 22, pp. 2358-2370
Open Access | Times Cited: 16
Mathilde Poplineau, Nadine Platet, Adrien Mazuel, et al.
Blood (2022) Vol. 140, Iss. 22, pp. 2358-2370
Open Access | Times Cited: 16